Advances in Inflammatory Bowel Diseases

Front Cover
P. Rutgeerts, J-F. Colombel, S.B. Hanauer, J. Schölmerich, Guido Tytgat, A. van Gossum
Springer Science & Business Media, Dec 31, 1998 - Medical - 320 pages
Ulcerative colitis and Crohn's disease remain a great therapeutic challenge to the medical community. In recent years knowledge about the pathogenesis of these diseases has progressed rapidly but the cause of the diseases remains completely unknown. It has become clear that dysregulation of the mucosal immune system is the basis for the chronic evolution of the diseases in a genetically susceptible population. Exciting new therapeutic approaches have been attempted in the last couple of years and cytokine and anti-cytokine treatments in particular seem very promising, especially in intractable disease.
The format of the Falk Symposium 106 on `Advances in Inflammatory Bowel Diseases', held in Brussels, Belgium, June 18-20, 1998, was somewhat innovative as each session attempted to link the new insights into pathogenetic mechanisms with new therapeutic approaches, resulting in optimal information transfer. The classic therapeutic schemes were updated with a special focus on step-wise build-up of therapy.
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

III
3
IV
17
V
24
VI
34
VIII
43
IX
55
X
68
XI
80
XXI
188
XXII
201
XXIII
210
XXIV
218
XXV
227
XXVI
233
XXVII
244
XXVIII
251

XII
89
XIII
105
XIV
112
XV
130
XVI
135
XVII
145
XVIII
159
XIX
168
XX
185
XXIX
257
XXX
269
XXXI
275
XXXII
280
XXXIII
288
XXXIV
297
XXXV
301
XXXVI
311
Copyright

Common terms and phrases

Bibliographic information